Dr. Reddy Laboratories’ Profitability – An Overview

Price: 350 Add to Cart
Details
Case Code:

FINC152

Case Length:

7

Period:

2016-2018

Pub Date:

2019

Teaching Note:

YES

Price (Rs):

350

Organization:

Dr. Reddy Laboratories

Industry:

Pharmaceutical

Country:

India

Themes:

Working Capital Management,Strategic Cost Management, Financial Forecasting

Abstract

The management of India-based pharmaceutical company Dr. Reddy Laboratories observed that the company had not fared as expected in the fiscal year 2017-18 as result of increasing competition in the global markets – particularly the US market – challenges in complying with international regulatory controls, and the changing dynamics of the Indian market. The management intended to keep a close watch on the changing market dynamics and to implement strategies to improve revenue share. At the same time, it was also focussing on reducing unnecessary costs and expenses to achieve its objectives of improving profitability for the fiscal year 2018-19. The present case study provides information regarding the various sources of revenue and income of the company and the expenses it incurred to analyze the profitability position of the company using key profitability ratios like the gross profit ratio, operating profit ratio, and the net profit ratio and also to figure out the impact of tax on the net profit available to the shareholders.

Learning Objectives

The case is structured to achieve the following Learning Objectives:

  • The process of analyzing and interpreting the profitability position of a company.
  • The difference between various profitability ratios.
  • The profitability position of Dr Reddy Laboratories.
Keywords

Profitability of Dr.Reddy Laboratories; Current Ratio; Quick Ratio; Cash Ratio; Overall Liquidity; Current Assets; Current Liabilities; Quick Assets

Move to top